Original Research
Published on 06 Sep 2022
A novel 16-gene alternative mRNA splicing signature predicts tumor relapse and indicates immune activity in stage I–III hepatocellular carcinoma
in Gastrointestinal and Hepatic Pharmacology
- 2,466 views
- 3 citations